the SENOMAC trial

the SENOMAC trial - arm morbidity and health-related quality of life

The main aim of the SENOMAC trial is to achieve an undiminished oncological safety while offering a reduction of arm-related functional symptoms, pain and swelling (lymphedema). To this end, participating individuals will be asked to provide information about symptoms from their arm and shoulder as well as about their health-related quality of life, symptoms of anxiety and depression. The selected questionnaires include:

• EORTC QLQ-C30
• EORTC BR-23
• Lymph-ICF
• EQ-5D

This part of the SENOMAC trial has an own trial sub-committee including

• Ass. Prof. Jana de Boniface (as the Coordinating Investigator)
  
• Ass. Prof. Karin Johansson, physiotherapist, Lund University
• Dr. Helena Ikonomidis Sackey, surgeon, Karolinska University Hospital and Karolinska Institutet
  
• Matilda Appelgren, registered nurse, PhD student, Karolinska Institutet
• Prof. Yvonne Wengström, Karolinska Institutet